SUMMARYPlasma concentrations of IFN-a are increased in several inflammatory conditions. Several lines of evidence indicate that IFN-a has anti-inflammatory properties. To study the effects of IFN-a on leucocyte subsets and activation and on cytokines, we administered IFN-a (rhIFN-a2b; 5 × 10 6 U/m 2 ) to eight healthy human subjects in a randomized controlled cross-over study and analysed changes in circulating leucocytes and parameters for neutrophil and monocyte activation. After administration of IFN-a, neutrophil counts increased, monocyte counts decreased transiently, whereas the number of lymphocytes, basophils and eosinophils showed a sustained decrease. IFN-a administration was also associated with neutrophil activation, reflected in an increase in the plasma concentrations of elastasea 1 -antitrypsin complexes and lactoferrin. Serum neopterin, a marker for monocyte activation, was significantly increased 10 h after administration of IFN-a. IFN-a significantly increased plasma concentrations of IL-6, IL-8 and IL-10. Although IL-1 and tumour necrosis factor (TNF) remained undetectable, plasma concentrations of soluble TNF receptors p55 and p75 increased after IFN-a administration. We conclude that IFN-a induces multiple alterations in the distribution and functional properties of leucocytes. IFN-a exerts pro-as well as anti-inflammatory effects within the cytokine network.